Balchem Corporation (FRA:BL9B)

Market Cap	4.34B -10.9%
Revenue (ttm)	917.04M +9.6%
Net Income	137.10M +15.8%
EPS	4.22 +16.8%
Shares Out	n/a
PE Ratio	31.66
Forward PE	27.00
Dividend	0.82 (0.62%)
Ex-Dividend Date	Dec 23, 2025

Volume	n/a
Open	133.40
Previous Close	131.90
Day's Range	133.40 - 133.40
52-Week Range	118.60 - 154.80
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 31, 2026

About Balchem

Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended ...

• Industry: Industrial Organic Chemicals
• Founded: 1967
• Employees: 1,368
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: BL9B

Financial Performance

In 2025, Balchem's revenue was $1.04 billion, an increase of 8.75% compared to the previous year's $953.68 million. Earnings were $154.85 million, an increase of 20.53%.

Financial numbers in USD